Skip to main content
. 2021 Mar 19;150:e539–e549. doi: 10.1016/j.wneu.2021.03.062

Table 3.

Results of Stanford Press-Ganey Likelihood-to-Recommend (LTR) Scores from January 2019 Through August 2020

Press-Ganey LTR
Subspecialty Phase 0
Jan 2019–Dec 2019
Phase 1
Jan 2020–Feb 2020
Phase 2
Mar 2020 - Apr 2020
Phase 3
May 2020–Aug 2020
P-value
Phase 0 to Phase 1
P Value
Phase 0 to Phase 2
P Value
Phase 0 to Phase 3
P Value
Phase 2 to Phase 3
Spine 84.4% ± 36.2% 90.1% ± 29.9% 91.3% ± 28.5% 87.3% ± 33.5% 0.1 0.21 0.45 0.48
Tumor 88.1% ± 32.4% 87.7% ± 33.1% 85.7% ± 35.6% 81% ± 39.6% 0.92 0.71 0.12 0.59
Vascular 87.9% ± 32.7% 87.5% ± 33.8% 85.7% ± 36.3% 92.6% ± 26.7% 0.96 0.81 0.49 0.49
Functional 91.1% ± 28.6% 81.8% ± 39.5% 100% ± 0% 88.9% ± 32.3% 0.19 0.35 0.77 0.32
Peripheral Nerve 95.1% ± 21.7% 100% ± 0% 85.7% ± 36.3% 95% ± 22.4% 0.58 0.17 0.99 0.36
Trauma 90.9% ± 30.2% 100% ± 0% 0.69
Total 87.3% ± 33.3% 88.7% ± 31.7% 89.2% ± 31.2% 87% ± 33.8% 0.54 0.56 0.9 0.56